Individual digital health devices are increasingly being bundled together as interacting, multicomponent suites, to deliver clinical services (e.g., teleconsultation and ‘hospital-at-home services’). In the first article of this two-article series we described the challenges in implementation and the current limitations in frameworks for the regulation, health technology assessment, and reimbursement of these device suites and linked novel care pathways. A flexible and fit-for-purpose evaluation framework that can analyze the strengths and weaknesses of digital technology suites is needed. In this second article we describe adaptations that could enable this new technological paradigm while maintaining patient safety and fair value.

中文翻译：

---

监管和报销如何更好地适应灵活的数字医疗技术套件？


个人数字健康设备越来越多地捆绑在一起作为交互的多组件套件，以提供临床服务（例如，远程会诊和“家庭医院服务”）。在这个两篇文章系列的第一篇文章中，我们描述了实施中的挑战以及这些设备套件的监管、卫生技术评估和报销框架的当前限制以及相关的新颖护理途径。需要一个灵活且适合目的的评估框架来分析数字技术套件的优势和劣势。在第二篇文章中，我们描述了可以在保持患者安全和公平价值的同时实现这种新技术范例的调整。